DRUG · Mapped RxNorm record
Mirtazapine
Normalized identity: mirtazapineView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM (M2.0)
NCT01888835
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedMirtazapine for the Treatment of Methamphetamine Dependence Among MSM (M2.0)
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Amphetamine-Related Disordersunresolved
Interventions
MirtazapineDRUG · verified · RxNorm: mirtazapine
PlaceboDRUG
Sponsors & collaborators
Phillip Coffin, MD, MIAlead sponsor
National Institute on Drug Abuse (NIDA)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01888835 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.